Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMFTAWU)

Drug Name	mRNA-2416 DMFTAWU
Synonyms	mRNA-OX40L
Drug Type	mRNA therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

3 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Solid tumour/cancer	DISZR48F	2A00-2F9Z	Phase 1	[1]
Lymphoma	DISN6V4S	2A80-2A86	Phase 1	[1]
Ovarian cancer	DISZJHAP	2C73	Phase 1	[2]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT03323398) Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies. U.S. National Institutes of Health.